The proarrhythmic effect of hypoglycemia: evidence for increased risk from ischemia and bradycardia

Area of Science:

• Cardiology
• Electrophysiology
• Endocrinology

Background:

• Hypoglycemia is linked to increased mortality, including sudden death.
• Cellular mechanisms of hypoglycemia mimic proarrhythmic drug effects on myocardial tissue.
• Emerging evidence suggests ischemia and bradycardia as key hypoglycemia-induced proarrhythmic factors.

Purpose of the Study:

• To review the emerging evidence linking hypoglycemia to cardiac arrhythmias and sudden death.
• To elucidate the cellular and physiological mechanisms by which hypoglycemia promotes cardiac instability.
• To highlight ischemia and bradycardia as significant contributors to hypoglycemia-induced arrhythmias.

Main Methods:

• Review of historical data from "insulin shock" therapy.
• Analysis of recent studies on hypoglycemia's effects on myocardial physiology.
• Examination of cellular electrophysiological changes induced by reduced serum glucose.
• Investigation of the sympathetic response to hypoglycemia and its arrhythmic potential.

Main Results:

• Hypoglycemia blocks the HERG K+ channel, prolonging action potential and QT interval, increasing torsades de pointes risk.
• Sympathetic activation during hypoglycemia can cause Ca2+ overload, leading to arrhythmias.
• Hypoglycemia induces myocardial ischemia through various mechanisms, potentially creating a positive feedback loop for electrophysiological destabilization.
• Hypoglycemia can cause bradycardia and heart block, further potentiating arrhythmias, especially with concurrent low serum potassium.

Conclusions:

• Hypoglycemia is a significant proarrhythmic event, contributing to increased risk of sudden cardiac death.
• The mechanisms include direct effects on ion channels, sympathetic activation, induced ischemia, and bradycardia.
• Understanding these pathways is crucial for managing patients at risk of hypoglycemia-associated cardiac events.